Literature DB >> 10619658

A novel cellular prion protein isoform present in rapid anterograde axonal transport.

K Rodolfo1, R Hässig, K L Moya, Y Frobert, J Grassi, L Di Giamberardino.   

Abstract

We studied the axonal transport of PrP(C) in hamster retinal and sciatic nerve axons. Our results show that a novel 38kDa form is the predominant form in rapid anterograde axonal transport while the 36kDa and 33kDa PrP(C) forms, abundant in nerve and brain, appear to be either stationary or slowly transported. We did not detect any significant retrograde transport of PrP(C). These results show that 38kDa PrP(C) is the form exported from the cell body to the axonal compartment where it may represent the precursor to the more abundant PrP(C) forms after its modification in nerve fibres or terminals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619658     DOI: 10.1097/00001756-199911260-00032

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Subcellular localization of disease-associated prion protein in the human brain.

Authors:  Gábor G Kovács; Matthias Preusser; Michaela Strohschneider; Herbert Budka
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 2.  The role of the prion protein in the molecular basis for synaptic plasticity and nervous system development.

Authors:  Sandra E Encalada; Kenneth L Moya; Sylvain Lehmann; Ralph Zahn
Journal:  J Mol Neurosci       Date:  2007-06-14       Impact factor: 3.444

Review 3.  Copper-dependent functions for the prion protein.

Authors:  David R Brown; Judyth Sassoon
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

4.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

5.  Stable kinesin and dynein assemblies drive the axonal transport of mammalian prion protein vesicles.

Authors:  Sandra E Encalada; Lukasz Szpankowski; Chun-hong Xia; Lawrence S B Goldstein
Journal:  Cell       Date:  2011-02-18       Impact factor: 41.582

6.  Evaluation of quinacrine treatment for prion diseases.

Authors:  A Barret; F Tagliavini; G Forloni; C Bate; M Salmona; L Colombo; A De Luigi; L Limido; S Suardi; G Rossi; F Auvré; K T Adjou; N Salès; A Williams; C Lasmézas; J P Deslys
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  GFP-tagged mutant prion protein forms intra-axonal aggregates in transgenic mice.

Authors:  Andrea Z Medrano; Sami J Barmada; Emiliano Biasini; David A Harris
Journal:  Neurobiol Dis       Date:  2008-04-07       Impact factor: 5.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.